Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age
Public ClinicalTrials.gov record NCT00192140. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Single-Arm Trial to Assess the Shedding, Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
* To describe the proportion of individuals 5-49 years of age who shed vaccine strain viruses. * To describe the duration of shedding of vaccine viruses in individuals 5-49 years of age. * To describe the genotypic and phenotypic stability of shed vaccine viruses. * To describe the immune responses of FluMist in individuals 5-49 years of age. * To describe the safety of FluMist in individuals 5-49 years of age in relation to shedding and the immune response
Study identification
- NCT ID
- NCT00192140
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 345 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 5 Years to 49 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2004
- Primary completion
- Sep 30, 2004
- Completion
- Dec 31, 2004
- Last update posted
- Dec 27, 2007
2004 – 2005
United States locations
- U.S. sites
- 11
- U.S. states
- 11
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| SFBC International, Inc | Miami | Florida | 33181 | — |
| Children's Memorial Hospital | Chicago | Illinois | 60614 | — |
| Kentucky Pediatric / Adult Research, Inc | Bardstown | Kentucky | 40004 | — |
| University of Maryland, School of Medicine | Baltimore | Maryland | 21201 | — |
| Center for Vaccine Development | St Louis | Missouri | 63110 | — |
| Creighton University Medical Center | Omaha | Nebraska | 68131 | — |
| Pediatric Clinical Trials International | Columbus | Ohio | 43205 | — |
| Primary Physician's Research Inc. | Pittsburgh | Pennsylvania | 15241 | — |
| Vanderbilt University Medical Center North | Nashville | Tennessee | 37232 | — |
| University of Virginia, Elson Student Health Center | Charlottesville | Virginia | 22904 | — |
| Marshall University Medical Center | Huntington | West Virginia | 25701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00192140, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 27, 2007 · Synced Sep 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00192140 live on ClinicalTrials.gov.